ACTA1 and Hepatic fibrosis: Reduction in hepatocellular steatosis, inflammatory reaction and decrease expression of α-SMA by proliferated HSCs by the three therapeutic agents either Si+CCl4 or F-Et and B-Et might be the possible mechanism of hepatoprotection against CCl4 induced liver fibrosis.